research

Members of the Lauver Lab presented their work at the Gull Lake Hypertension Meetings

Members of the Lauver Lab presented their work at the Gull Lake Hypertension Meetings on May 3, 2019:

img_2704.jpg

Dawn Henderlong, Graduate Student

Mechanistic differences in the antiplatelet effects of DT-678 and exisiting P2Y12 antagonists

Nick Ether, Graduate Student

Utilizing clinical adverse event reports to improve the prediction of arrhythmia risk during drug development.

Pharmaceutical Research and Manufacturers Association Research Starter Grant

Dr. Lauver was the recipient of the 2019 Pharmaceutical Research and Manufacturers Association (PhRMA) Foundation Research Starter Grant which was awarded during the Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics (ASPET) in Orlando. Thank you for your support!


Full Press Release: Link